STAT

Opinion: A community-guided genome editing project can fight Lyme disease

Even if there are differences of opinion about genetically engineering Lyme-resistant mice, ensuring that ecological engineering proposals start small and invite community guidance is a project everyone can support.

The epidemic of Lyme disease is an ecological problem of our own making: We have inadvertently altered our environment to maximize the number of infected ticks. The question today is whether we should consider altering the genomes of wild animals to undo that mistake.

See related opinion: Gene editing to stop Lyme disease: caution is warranted

If so, we should find the most minimal intervention that might solve the problem. We should actively invite suggestions, concerns, and guidance from interested local communities who know their own environments best. And we should initially observe the effects on mostly uninhabited islands.

That’s exactly what my colleagues and I aim, a community-guided project working to prevent tick-borne disease through genome editing.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks